RxDoctor Payments Data

Susan Murrmann, MD

Obstetrics & Gynecology · Germantown, TNNPI 1801893169

Payments from drug & device makers

$4,498in general payments, 2019–2025

Across 255 payments — averaging $17.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Bausch Health US, LLC$349
  • Aspira Women's Health Inc$329
  • Astellas Pharma US Inc$291
  • Biotissue Holdings Inc.$227
  • Mayne Pharma Commercial LLC$205
  • plus $2K from 33 others

What the payments were for

  • Speaking & faculty fees$2215%
  • Food & beverage$4,16693%
  • Education$1112%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,498 in reported general payments places this provider in the 85th percentile of 763 obstetrics & gynecology providers in Tennessee.

See all obstetrics & gynecology providers in Tennessee

Medicare billing

Part B allowed, 2024
$65,967
Medicare patients
240
Services billed
1,906

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol106$4,871
ProgesteroneProgesterone, Micronized179$4,315
ImvexxyEstradiol14$3,956
Vivelle-DotEstradiol16$3,476
Estradiol (Twice Weekly)Estradiol28$2,685
Acyclovir11$1,622
LyllanaEstradiol17$1,144
Liothyronine Sodium24$847
SynthroidLevothyroxine Sodium13$691
Bupropion XlBupropion Hcl17$368
Fluconazole18$202
Levothyroxine Sodium33$200
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst11$172
Atorvastatin Calcium13$153
Metformin Hcl21$105

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Therapeuticsmd, Inc.Imvexxy$172$3,95614 claims
AbbVieSynthroid$1,240$69113 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 763 obstetrics & gynecology providers in Tennessee.

Other obstetrics & gynecology in Germantown

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →